The Autonomic Nervous System (ANS) is a division of the peripheral nervous system that regulates involuntary bodily functions such as heart rate, digestion, respiration, and perspiration. It is composed of two branches: the sympathetic nervous system and the parasympathetic nervous system. The ANS is a key component of neurology, as it is responsible for controlling the body's response to stress and other external stimuli.
The ANS market is a rapidly growing segment of the neurology industry. Companies in this market are focused on developing treatments and therapies for conditions related to the ANS, such as hypertension, diabetes, and Parkinson's disease. These treatments range from lifestyle modifications to medications and surgical interventions. Additionally, research and development of new technologies and treatments for ANS-related conditions is a major focus of the market.
Some of the major companies in the ANS market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are actively engaged in research and development of new treatments and therapies for ANS-related conditions. Show Less Read more
